Table 4.
FDA Approved Liquid Biopsies
| Name of Liquid Biopsy | Targets | Types of Cancer Used For | Manufacturer |
|---|---|---|---|
| CELLSEARCH® Circulating Tumor Cell Assay | Detects circulating tumor cells (CTC) of epithelial origin (CD45−, EpCAM+, and cytokeratins 8, 18+, and/or 19+) | Metastatic breast, prostate, and colorectal cancer | Menarini Silicon Biosystems |
| cobas® EGFR Mutation Test v2 | Detects 42 mutations in exons 18, 19, 20 and 21 of the epidermal growth factor receptor (EGFR) gene, including the T790M resistant mutation | Non-small cell lung cancer (NSCLC) | Roche Molecular Systems |
| therascreen® PIK3CA RGQ PCR kit. | Detects 11 mutations in exons 7, 9, and 20 of the PIK3CA gene | PIK3CA mutated HR+/HER2− advanced breast cancer | QIAGEN |